NCT02797236View on ClinicalTrials.gov

SF2a-TT15 Conjugate Vaccine in Healthy Adult Volunteers

PHASE1CompletedINTERVENTIONAL

Enrollment

64

Participants

Timeline

Start Date

September 30, 2016

Primary Completion Date

June 30, 2017

Study Completion Date

December 31, 2017

Conditions

ShigellosisBacillary Dysentery

Interventions

BIOLOGICAL

SF2a-TT15 vaccine

BIOLOGICAL

SF2a-TT15 vaccine + adjuvant

BIOLOGICAL

Placebo

BIOLOGICAL

Placebo + adjuvant

Trial Locations (1)

Unknown

Tel Aviv Souraski Medical Center, Tel Aviv

Sponsors

Lead Sponsor

Institut Pasteur

All Listed Sponsors

lead

Institut Pasteur

INDUSTRY